SCHEMBL2170099

SCHEMBL2170099

CC(C)c1ccc(S(=O)(=O)Nc2ccc(OC(F)(F)F)c(NC3CCN(C)CC3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.47
CYP2D6 P10635 3/20 0.47
HTR6 P50406 6/20 0.44
TRIM24 O15164 1/20 0.44
BRD1 O95696 1/20 0.44
BRPF1 P55201 1/20 0.44
DRD2 P14416 3/20 0.41
KCNH2 Q12809 3/20 0.41
DRD3 P35462 2/20 0.41
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
SLC2A1 P11166 1/20 0.40
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
HTR7 P34969 2/20 0.40
ADRA1B P35368 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2170724 0.89 CYP3A4 (0.59) CYP3A4CYP2D6HTR6TRIM24BRD1
SCHEMBL2169531 0.83 HTR6 (0.49) CYP3A4CYP2D6HTR6TRIM24BRD1
SCHEMBL2169936 0.83 HTR6 (0.49) CYP3A4CYP2D6HTR6TRIM24BRD1
Hydrochloric Acid SCHEMBL2183767 0.82 HTR6 (0.48) CYP3A4CYP2D6HTR6TRIM24BRD1
SCHEMBL2169701 0.81 HTR6 (0.47) CYP3A4CYP2D6HTR6DRD2DRD3
SCHEMBL2170321 0.79 CYP3A4 (0.59) CYP3A4CYP2D6HTR6DRD2KCNH2
SCHEMBL6118004 0.78 SLC2A1 (0.53) CYP3A4HTR6TRIM24BRD1BRPF1
SCHEMBL2172325 0.77 CYP3A4 (0.60) CYP3A4CYP2D6HTR6DRD2KCNH2
SCHEMBL2170708 0.76 HTR6 (0.63) CYP3A4CYP2D6HTR6TRIM24BRD1
SCHEMBL5835561 0.75 UTS2R (0.65) HTR6TRIM24BRD1BRPF1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346847-B1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2013-05-15 EP claimed
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2012-05-24 US claimed
EP-2346847-B1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LTD (IN) 2013-05-15 EP disclosed
US-8404720-B2 Aryl sulfonamide amine compounds and their use as 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2013-03-26 US disclosed
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2012-05-24 US disclosed
EP-2346847-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS Suven Life Sciences Limited (IN) 2011-07-27 EP disclosed
WO-2010032258-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129816-A1 ARYL SULFONAMIDE AMINE COMPOUNDS AND THEIR USE AS 5-HT6 LIGANDS HTR6, HTR1A, HTR5A CYP3A4 119/4885CYP2D6 23/4885HTR6 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.